News

Bausch + Lomb recalls lenses used in cataract surgery due to inflammatory reactions
Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...
Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Bausch + Lomb announces lenses recall: Here’s what to know
The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety ...
StockStory.org on MSN6d
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...
Bausch Health: Repositioning Aplezin As First Oral Monotherapy For TRD A $3 Billion Opportunity
Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...
Monthly Prescribing Reference2d
Bausch + Lomb Issues Recall of enVista Lenses Used in Cataract Surgery
Recall issued in response to reports of toxic anterior segment syndrome. HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the ...
ConsumerAffairs5d
Bausch + Lomb recalls some enVista intraocular lenses
Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company ...
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / ...
Pharmabiz1d
Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris
Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris: Laval, Quebec Saturday, April 12, 2025, 10:00 Hrs [IST] Bausch Hea ...
KPVI3d
Bausch + Lomb Issues Recall of enVista Lenses Used in Cataract Surgery
Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an ...
Morningstar3d
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10 ...